Clinical trial · Observational
Lateral Approach for Mediastinal Lymph Node Dissection in Thyroid Cancer
Thyroid Cancer Superior Mediastinal Lymph Node Dissection Via Lateral Cervical Approach: Exploration and Practice of a Novel Surgical Pathway
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Despite the numerous surgical approaches available for superior mediastinal lymph node dissection in thyroid cancer, many of these methods still have significant limitations. In this study, we report for the first time a novel surgical technique for superior mediastinal lymph node dissection: a thyroid cancer surgery based on a lateral cervical approach. This technique offers a new surgical option for the dissection of superior mediastinal lymph nodes in thyroid cancer.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lymph Node Metastasis | — | UNRESOLVED | — |
| Mediastinal Diseases | — | UNRESOLVED | — |
| Thyroid Cancer | Malignant Thyroid Gland Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (5)
- measure
- Number of upper mediastinal lymph nodes dissected
- timeFrame
- 1day
- description
- Postoperative pathological records
- measure
- Duration of surgery
- timeFrame
- 1day
- description
- Described in the surgical record
- measure
- Postoperative complications
- timeFrame
- 1 month
- description
- According to the follow-up data
- measure
- Surgical blood loss
- timeFrame
- 1day
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: 1. All patients who underwent thyroid cancer superior mediastinal lymph node dissection via the lateral cervical approach in our department. 2. Complete hospitalization records, ensuring that the patient's surgical records, pathological examinations, and other information are fully traceable. 3. Complete postoperative follow-up data, including complications during the follow-up period. 4. No other severe comorbidities, to avoid surgical outcome bias caused by other diseases. 5. No distant metastasis found preoperatively, or distant metastasis is still assessable for effective treatment. Exclusion Criteria: 1. Cases with incomplete data, such as missing hospitalization records or incomplete follow-up data. 2. Systemic diseases with severe heart, lung, liver, kidney, or brain dysfunction that may affect the accuracy of data. 3. Patients with severe coagulopathy. 4. Tumor pathology indicating undifferentiated thyroid cancer, malignant lymphoma, or non-thyroid-origin tumors.
References
Publications (0)
Data not yet available